Tromp G, Kuivaniemi H, Raphael S, Ala-Kokko L, Christiano A, Considine E, Dhulipala R, Hyland J, Jokinen A, Kivirikko S, Korn R, Madhatheri S, McCarron S, Pulkkinen L, Punnett H, Shimoya K, Spotila L, Tate A, Williams C J
Department of Biochemistry, Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, USA.
Am J Hum Genet. 1996 Nov;59(5):1097-107.
Blau syndrome (MIM 186580), first described in a large, three-generation kindred, is an autosomal, dominantly inherited disease characterized by multiorgan, tissue-specific inflammation. Its clinical phenotype includes granulomatous arthritis, skin rash, and uveitis and probably represents a subtype of a group of clinical entities referred to as "familial granulomatosis." It is the sole human model with recognizably Mendelian inheritance for a variety of multisystem inflammatory diseases affecting a significant percentage of the population. A genomewide search for the Blau susceptibility locus was undertaken after karyotypic analysis revealed no abnormalities. Sixty-two of the 74-member pedigree were genotyped with dinucleotide-repeat markers. Linkage analysis was performed under a dominant model of inheritance with reduced penetrance. The marker D16S298 gave a maximum LOD score of 3.75 at theta = .04, with two-point analysis. LOD scores for flanking markers were consistent and placed the Blau susceptibility locus within the 16p12-q21 interval.
布劳综合征(MIM 186580),最初在一个大型的三代家族中被描述,是一种常染色体显性遗传病,其特征为多器官、组织特异性炎症。其临床表型包括肉芽肿性关节炎、皮疹和葡萄膜炎,可能代表了一组被称为“家族性肉芽肿病”的临床实体的一个亚型。它是唯一一种具有明显孟德尔遗传特征的人类模型,用于研究影响相当一部分人群的多种多系统炎症性疾病。在核型分析未发现异常后,开展了全基因组搜索布劳易感性位点的研究。在这个74名成员的家系中,62人用二核苷酸重复标记进行了基因分型。连锁分析在显性遗传模型下进行,外显率降低。在两点分析中,标记D16S298在θ = 0.04时给出了最大LOD值3.75。侧翼标记的LOD值一致,将布劳易感性位点定位于16p12 - q21区间内。